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Items for this week’s EPI Update include: 
• Influenza widespread in Iowa, antiviral reminder 
• Type F infant botulism - very rare, but cases in Iowa  
• Many hep C cases don’t get confirmatory testing 
• In the news: Salmonella Infection Linked to Rattlesnake Pills 
• In the news: CRISPR put to work to save chocolate 
• Infographic: Cover your cough 
• Meeting announcements and training opportunities 
 
Influenza widespread in Iowa, antiviral reminder 
Influenza activity and geographic spread in Iowa are increasing significantly and 
21 influenza outbreaks in long-term care facilities have been investigated so far 
this season. Outpatient visits for influenza-like illness were higher last week than 
last season’s peak, and about 25 percent of the over 2000 rapid flu tests done 
last week were positive for influenza. SHL confirmed influenza in131 of 
158 samples sent to them last week; this is higher than last season’s peak week. 
Influenza A(H3) has been the predominant strain this season, accounting for 390 
of 502 (78%) positive results. 
 
Seasons when A(H3N2) virus pre-dominate are associated with high levels of 
hospitalizations and deaths among all ages, but especially the elderly and very 
young children. Thus, it is important to use antiviral medications, both for treating 
and preventing influenza. Antiviral treatment is recommended to start as early as 
possible for any patient with confirmed or suspected influenza who is 
hospitalized, has severe complicated or progressive illness, or is at high risk for 
influenza complications. Influenza antiviral medication can also be used as post-
exposure prophylaxis in certain situations, such as during influenza outbreaks in 
long-term care facilities. 
 
For more information on antiviral use for influenza, 
visit www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm.  
 
To view the IDPH press release, visit 
idph.iowa.gov/News/ArtMID/646/ArticleID/158197/Flu-Deaths-Rise-in-Iowa-1518.  
 
Type F infant botulism - very rare, but cases in Iowa  
A study of recent cases of Type F infant botulism, including three in Iowa, has 
been published. Only 18 cases have ever been reported in the U.S. and Iowa is 
tied with California for reporting the most cases (3). Type F infant botulism is 
generally more severe than infant botulism caused by more common types, and 
occurs earlier in infants. No exposure source for Type F infant botulism has ever 
been identified, despite intensive investigations.   
 
If you suspect a case of infant botulism, please contact IDPH immediately!  
Human botulism immune globulin is available through IDPH and CDC to treat the 
most common types of infant botulism (though it is not effective for Type F infant 
botulism). Infants with Type F infant botulism can be treated with equine-derived 
adult heptavalent (A–G) botulism antitoxin (after consultations with national 
experts). 
 
To view the article, visit academic.oup.com/cid/article/66/suppl_1/S92/4780427.  
 
Many hep C cases don’t get confirmatory testing 
In 2016, 2,287 Iowans were diagnosed with hepatitis C virus (HCV), but 30 
percent did not have a confirmatory (i.e., RNA) test to identify chronic infection. 
These confirmatory tests are essential to identify patients with chronic infections, 
who need to discuss treatment options with their health care provider.  
 
An estimated 15 to 25 percent of people with HCV antibodies may clear the virus 
spontaneously. Thus, CDC recommends that a HCV RNA confirmatory test be 
done when a patient has a reactive antibody result. IDPH is starting to follow-up 
with providers of patients who are reported with HCV without evidence of a 
confirmatory result. To view an algorithm for HCV confirmatory testing, visit 
www.cdc.gov/hepatitis/hcv/pdfs/hcv_flow.pdf. Detailed guidance for clinicians 
and laboratorians on testing for HCV can be found at 
www.cdc.gov/mmwr/pdf/wk/mm62e0507a2.pdf.  
 
In the news: Salmonella Infection Linked to Rattlesnake Pills 
www.cdc.gov/media/releases/2017/s1219-salmonella-rattlesnake-pills.html  
 
In the news: CRISPR put to work to save chocolate 
news.berkeley.edu/story_jump/crispr-put-to-work-to-save-chocolate-from-
devastation/  
 
Infographic: Cover your cough 
 
 
The poster is also available in the following languages: Amharic, Arabic, Bengali, 
Burmese, Chinese, French, Hebrew, Hindi, Hmong, Karen, Khmer, Lao, Nepali, 
Oromo, Portuguese, Russian, Somali, Spanish, Tagalog and Vietnamese. 
 
To view in full size and in other languages, visit 
www.health.state.mn.us/divs/idepc/dtopics/infectioncontrol/cover/gen/genposter.
html. 
 
Meeting announcements and training opportunities 
MMWR is expanding its offering of continuing education activities (for doctors, 
nurses, pharmacists, veterinarians and more) on a monthly basis. To access 
current and future MMWR CME activities, visit 
www.cdc.gov/mmwr/cme/medscape_cme.html.  
 
Have a healthy and happy week, and 2018! 
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